CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Entero Therapeutics Inc - ENTO CFD

2.6329
4.71%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.1242
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.001
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.7629
Open 2.6429
1-Year Change 21.95%
Day's Range 2.6329 - 2.7529
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
May 23, 2024 2.7629 0.1000 3.76% 2.6629 2.8429 2.6129
May 22, 2024 2.8929 0.1000 3.58% 2.7929 2.8929 2.7929
May 21, 2024 2.8029 0.0100 0.36% 2.7929 2.8729 2.6029
May 20, 2024 2.8329 -0.0100 -0.35% 2.8429 2.9429 2.8029
May 16, 2024 2.9429 0.1200 4.25% 2.8229 3.0029 2.8229
May 15, 2024 2.7629 -0.2000 -6.75% 2.9629 2.9629 2.7129
May 14, 2024 2.8229 -0.0200 -0.70% 2.8429 3.0429 2.7429
May 13, 2024 2.9329 0.1700 6.15% 2.7629 2.9529 2.7629
May 10, 2024 2.8129 0.1700 6.43% 2.6429 2.8129 2.5929
May 9, 2024 2.8190 0.1000 3.68% 2.7190 2.8490 2.6990
May 8, 2024 2.7290 0.0900 3.41% 2.6390 2.7890 2.6390
May 7, 2024 2.6390 0.1100 4.35% 2.5290 2.6790 2.4990
May 6, 2024 2.5990 0.0000 0.00% 2.5990 2.6590 2.3090
May 3, 2024 2.5890 -0.1100 -4.08% 2.6990 2.8490 2.5890
May 2, 2024 2.7790 -0.0300 -1.07% 2.8090 2.8490 2.6490
May 1, 2024 2.7790 0.1300 4.91% 2.6490 2.8190 2.6490
Apr 30, 2024 2.6290 -0.0200 -0.76% 2.6490 2.6690 2.5890
Apr 29, 2024 2.5690 -0.1700 -6.21% 2.7390 2.8990 2.5490
Apr 26, 2024 2.7390 0.1200 4.58% 2.6190 2.7590 2.5290
Apr 25, 2024 2.7290 -0.2700 -9.00% 2.9990 2.9990 2.6490

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

First Wave BioPharma, Inc. Company profile

About First Wave BioPharma Inc

First Wave BioPharma, Inc., formerly AzurRx BioPharma, Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. It is focused on advancing a therapeutic development pipeline built around its two technologies: niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients. The Company's niclosamide portfolio is led by three clinical programs: FW-COV, for COVID-19 gastrointestinal infections; FW-UP, for ulcerative proctitis (UP) and ulcerative proctosigmoiditis; and FW-ICI-AC, for Grade 1 and Grade 2 immune checkpoint inhibitor-associated colitis and diarrhea in advanced oncology patients. It is also advancing FW-EPI (adrulipase) for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis and chronic pancreatitis.

Financial summary

BRIEF: For the nine months ended 30 September 2021, First Wave BioPharma Inc revenues was not reported. Net loss applicable to common stockholders increased from $23.4M to $73.2M. Higher net loss reflects Research and development expenses - Bala increase of 85% to $8.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$8.35 to -$10.31.

Industry: Biotechnology & Medical Research (NEC)

777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US

News

Copper price slumps as traders take profits, where to next?

Copper price drops over 5% on Thursday as traders take profits following the FOMC meeting minutes.

16:17, 24 May 2024

Market analysis: EUR/GBP driven by diverging policy expectations

The EURGBP is driven by the question: which cuts first, the ECB or the BOE? Currently, swaps markets (chart below) imply that it will be the ECB (blue line).

13:46, 24 May 2024

UK CPI Preview: Will inflation return to 2% as the BoE predicts? And how will it affect GBP?

The latest round of inflation data will be released at 22 April at 7 am BST and investors are likely going to be paying close attention.

15:44, 21 May 2024

Reserve Bank of New Zealand Preview: RBNZ could become more dovish as inflation eases and growth softens

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, May 22, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

15:29, 21 May 2024

Nvidia Q1 Earnings Preview: Analysts forecast another blockbuster set of results

Nvidia (NVDA) reports its Q1 results after the closing bell on Wednesday, May 22nd. We preview what to expect from Nvidia’s earnings and analyse its stock's technicals.

14:57, 21 May 2024
CPI, consumer price index symbol.

Disinflation resumes in the US as CPI drops in April

The rate of growth in US consumer prices dropped in April leading markets to price in more chances of rate cuts from the Fed

11:24, 16 May 2024

Stock market crash: how far can the S&P 500 go?

After a remarkably strong first quarter, the US stock market pulled back in April for the first time since October last year.

11:46, 10 May 2024

People also watch

Oil - Crude

77.71 Price
+0.900% 1D Chg, %
Long position overnight fee 0.0073%
Short position overnight fee -0.0293%
Overnight fee time 21:00 (UTC)
Spread 0.040

XRP/USD

0.54 Price
+2.800% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Gold

2,336.61 Price
+0.370% 1D Chg, %
Long position overnight fee -0.0199%
Short position overnight fee 0.0117%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

68,131.10 Price
+0.440% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading